MedPath

Does the Embryo Transfer Technique Affect the Success of in Vitro Fertilization?

Not Applicable
Conditions
Infertility
Assisted Reproductive Technology
IVF
Registration Number
NCT03756857
Lead Sponsor
Acibadem Kadiköy Hospital
Brief Summary

Prospective, open, randomized, parallel, two-arm trial to compare the clinical pregnancy rate between most commonly used two embryo transfer techniques: trial followed by transfer technique and afterloading technique

Detailed Description

Eligible patients will be informed about the possibility of participating in the clinical trial in the beginning of treatment and on the day ET, a signed consent form will be collected from those recipients who confirmed their participation. These patients will be randomized immediately before the ET procedure by sequentially numbered, opaque, sealed envelopes

Recruitment & Eligibility

Status
UNKNOWN
Sex
Female
Target Recruitment
200
Inclusion Criteria
  1. Patient has given written informed consent
  2. BMI 18-30 kg/m2
  3. < 2 previous failed IVF trials
  4. At least two good quality embryos on the day of transfer
Exclusion Criteria
  1. Congenital uterine anomaly
  2. Untreated endometrial polyp or fibroid distorting uterine cavity
  3. Presence of hydrosalpinx 4.2 or more prior IVF trial failure

5.Moderate to severe endometriosis 6.Recurrent pregnancy loss history

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
clinical pregnancy rate5-6 weeks after embryo transfer

the presence of gestational sac on ultrasound

Secondary Outcome Measures
NameTimeMethod
implantation rate3-4 weeks after embryo transfer

the number of gestational sacs divided by the number of embryos transferred

Trial Locations

Locations (1)

Acibadem Altunizade Hospital, Unit of ART

🇹🇷

İstanbul, Turkey

Acibadem Altunizade Hospital, Unit of ART
🇹🇷İstanbul, Turkey
Elif Esra Uyar, MD
Contact
+902166494444
esra.uyar@acibadem.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.